About Blue Heron Bio
Blue Heron Bio is a company based in Bothell (United States) founded in 1999 was acquired by Eurofins Genomics in August 2019. Blue Heron Bio has raised $3.68 million across 1 funding round from investors including OriGene, Eurofins Genomics and Life Technologies. Blue Heron Bio offers products and services including Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis. Blue Heron Bio operates in a competitive market with competitors including GSK, Avidity Biosciences, Poseida Therapeutics, Senti Biosciences and Sutro Biopharma, among others.
- Headquarter Bothell, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Blue Heron Biotech, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.68 M (USD)
in 1 rounds
-
Latest Funding Round
$3.68 M (USD), Series D
Jan 16, 2007
-
Investors
OriGene
& 4 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blue Heron Bio
Blue Heron Bio offers a comprehensive portfolio of products and services, including Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis.
Service for custom gene creation with fast turnaround for research.
Rapid production of DNA fragments for various applications.
Preparation of high-quality plasmids for experimental use.
Synthesis of oligonucleotides for research and sequencing.
Funding Insights of Blue Heron Bio
Blue Heron Bio has successfully raised a total of $3.68M through 1 strategic funding round. The most recent funding activity was a Series D round of $3.68 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Blue Heron Bio
Blue Heron Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include OriGene, Eurofins Genomics and Life Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Tools and technologies for biotech and biopharma research were supplied.
|
Locked | Locked | Locked |
Investor details for Blue Heron Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Blue Heron Bio
Investment portfolio details for Blue Heron Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Blue Heron Bio
Detailed financials for Blue Heron Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Blue Heron Bio Comparisons
Peer comparison for Blue Heron Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Blue Heron Bio
Blue Heron Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Poseida Therapeutics, Senti Biosciences and Sutro Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Cell-based therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
Detailed competitors of Blue Heron Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Blue Heron Bio
Complete news archive for Blue Heron Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blue Heron Bio
Blue Heron Bio was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Blue Heron Bio is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Blue Heron Bio is a funded company, having raised a total of $3.68M across 1 funding round to date.
Blue Heron Bio was founded in 1999 and is based in Bothell, United States. Operations center on biotechnology, with services focused on DNA design, gene synthesis, and sequencing. The proprietary Genemaker Technology platform is utilized to handle complex sequences, including large genes, hairpins, repeats, and GC-rich DNA. These capabilities support research and development in the life sciences sector.
Blue Heron Bio's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Blue Heron Bio offers Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis.
Blue Heron Bio has 5 investors. Key investors include OriGene, Eurofins Genomics, Life Technologies, Integra Ventures, and Taraval Associates.